kailashben mahendrabhai patel's Insider Trades & SAST Disclosures
kailashben mahendrabhai patel's most recent trade in Lincoln Pharmaceuticals Ltd. was a Acquisition of 11,500 Equity Shares done at an average price of Rs. 360.3 . Disclosure was reported to the exchange on Dec. 10, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
kailashben mahendrabhai patel's has made SAST transactions in Lincoln Pharmaceuticals Ltd. recently where a Acquisition of 11,500 shares done . Disclosure was reported to the exchange on Dec. 10, 2022.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lincoln Pharma | Kailashben Mahendrabhai Patel & PACs | Promoter | Acquisition | 13 Dec 2022 | 11,500 | 480,000 (2.40%) | 0.06% | - | 09 Dec 2022 09 Dec 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Kailashben Mahendrabhai Patel | Promoter Group | Acquisition | 10 Dec 2022 | 11,500 | 480,000 (2.40%) | 0.06% | 360.3 | 4,142,990 | 09 Dec 2022 09 Dec 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Kailashben Mahendrabhai Patel & PACs | Promoter | Acquisition | 09 Dec 2022 | 28,500 | 468,500 (2.34%) | 0.14% | - | 07 Dec 2022 07 Dec 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Kailashben Mahendrabhai Patel & PACs | Promoter | Acquisition | 07 Dec 2022 | 30,000 | 440,000 (2.20%) | 0.15% | - | 01 Dec 2022 01 Dec 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Kailashben Mahendrabhai Patel | Promoter Group | Acquisition | 07 Dec 2022 | 28,500 | 468,500 (2.34%) | 0.14% | 347.1 | 9,891,495 | 07 Dec 2022 07 Dec 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Kailashben Mahendrabhai Patel & PACs | Promoter | Acquisition | 06 Dec 2022 | 30,000 | 410,000 (2.05%) | 0.15% | - | 29 Nov 2022 29 Nov 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Kailashben Mahendrabhai Patel | Promoter Group | Acquisition | 03 Dec 2022 | 30,000 | 440,000 (2.20%) | 0.15% | 338.0 | 10,140,900 | 01 Dec 2022 01 Dec 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Kailashben Mahendrabhai Patel | Promoter Group | Acquisition | 30 Nov 2022 | 30,000 | 410,000 (2.05%) | 0.15% | 326.3 | 9,789,300 | 29 Nov 2022 29 Nov 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Kailashben Mahendrabhai Patel & PACs | Promoter | Acquisition | 31 Dec 2020 | 50,000 | 380,000 (1.90%) | - | - | 28 Dec 2020 28 Dec 2020 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Kailashben Mahendrabhai Patel | Promoter Group | Acquisition | 29 Dec 2020 | 25,000 | 380,000 (1.90%) | 0.13% | 227.5 | 5,687,000 | 29 Dec 2020 29 Dec 2020 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Kailashben Mahendrabhai Patel | Promoter Group | Acquisition | 29 Dec 2020 | 25,000 | 355,000 (1.78%) | 0.13% | 230 | 5,750,000 | 28 Dec 2020 28 Dec 2020 |
Insider Trading | Equity Shares | Market Purchase |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.